|
|
Volumn 1, Issue 2, 2001, Pages 147-154
|
|
Pulmonary embolism: from clinical presentation to clinical probability assessment.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRIN DEGRADATION PRODUCT;
FIBRIN FRAGMENT D;
COST BENEFIT ANALYSIS;
DIAGNOSTIC IMAGING;
ECHOGRAPHY;
ECONOMICS;
HUMAN;
LUNG;
LUNG EMBOLISM;
PREDICTION AND FORECASTING;
PROBABILITY;
PULMONARY ARTERY;
RADIOGRAPHY;
REVIEW;
RISK FACTOR;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
VEIN THROMBOSIS;
COST-BENEFIT ANALYSIS;
DIAGNOSTIC IMAGING;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
HUMANS;
LUNG;
PREDICTIVE VALUE OF TESTS;
PROBABILITY;
PULMONARY ARTERY;
PULMONARY EMBOLISM;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, SPIRAL COMPUTED;
VENOUS THROMBOSIS;
|
|
EID: 0037959063
PISSN: 15289648
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-18482 Document Type: Review |
|
Times cited : (11)
|
|
References (41)
|
